Introduction
Androgenetic alopecia is caused by a combination of genetic susceptibility and the body’s response to androgens, especially dihydrotestosterone (DHT). In people who are predisposed, hair follicles gradually become less able to produce normal terminal hairs and instead generate finer, shorter hairs over time. This develops through specific biological processes that alter the hair follicle’s growth cycle, reduce follicle size, and change how follicles respond to hormonal signals. The main causes can be grouped into inherited sensitivity to androgens, local hormonal activity in the scalp, and additional factors that influence whether and how quickly the condition appears.
Biological Mechanisms Behind the Condition
To understand why androgenetic alopecia occurs, it helps to know how normal hair growth works. Each follicle cycles through three broad phases: anagen, the active growth phase; catagen, a brief transitional phase; and telogen, a resting phase before shedding. In healthy scalp follicles, the anagen phase is long enough to produce thick, pigmented terminal hairs. In androgenetic alopecia, this cycle becomes progressively altered, with the growth phase shortening and the resting phase becoming relatively more prominent.
The key change is follicular miniaturization. Under the influence of androgens in genetically susceptible follicles, the dermal papilla and surrounding follicular cells signal the follicle to produce smaller hairs with shorter growth phases. Over successive cycles, the terminal hairs become thinner and less pigmented until they resemble fine vellus-like hairs. The follicle does not necessarily disappear, but its productive capacity is reduced.
The hormone most closely linked to this process is DHT, which is formed when the enzyme 5-alpha-reductase converts testosterone into a more potent androgen. DHT binds androgen receptors in susceptible scalp follicles more strongly than testosterone does. In affected individuals, this binding triggers changes in gene expression that alter growth factor signaling, dermal papilla function, and local inflammatory pathways. These molecular changes reduce the follicle’s ability to maintain normal hair production.
Another important feature is that not all scalp follicles respond the same way. Follicles in certain regions, such as the frontal hairline and vertex of the scalp, are more sensitive to androgen-driven miniaturization than follicles in the occipital scalp. This regional variation explains the characteristic distribution of thinning seen in androgenetic alopecia.
Primary Causes of Androgenetic alopecia
The strongest cause of androgenetic alopecia is inherited sensitivity to androgens. The condition is polygenic, meaning it is influenced by multiple genes rather than a single defect. Some of these genes affect androgen receptor activity, while others influence 5-alpha-reductase expression, follicle cycling, and the structure of hair follicles themselves. When a person inherits a follicle pattern that is highly responsive to DHT, the scalp follicles are more likely to miniaturize over time.
DHT-driven signaling is the central physiological mechanism. Testosterone circulates in the body normally, but in certain scalp follicles 5-alpha-reductase increases the local concentration of DHT. DHT then interacts with androgen receptors in the follicle’s dermal papilla cells, modifying the production of signaling molecules such as transforming growth factor beta, prostaglandins, and other regulators of follicle growth. These signals encourage the follicle to enter shorter growth cycles and reduce the diameter of each new hair shaft.
Local follicular susceptibility is another major cause. The scalp is not hormonally uniform. Follicles in androgenetic alopecia-prone areas have different receptor density, enzyme activity, and connective tissue responses compared with more resistant regions. As a result, two follicles exposed to similar hormone levels may behave very differently depending on their underlying biology.
Age also contributes because follicular changes accumulate over time. Although the predisposition is usually present earlier in life, the visible pattern often becomes more apparent as repeated hair cycles lead to progressive miniaturization. Aging may also reduce the regenerative capacity of follicular stem cells and alter the scalp microenvironment, making follicles less resilient to androgenic signaling.
Contributing Risk Factors
Genetics is the most important risk factor. A family history of patterned hair loss increases the likelihood that a person has inherited androgen-sensitive follicles. The inheritance pattern is complex and can come from either side of the family. Risk is not determined only by whether a parent has hair loss, but also by how many susceptibility genes were passed down and how strongly they are expressed.
Hormonal factors influence onset and progression. Higher local or systemic androgen activity can intensify miniaturization in susceptible follicles, although androgenetic alopecia does not require abnormal hormone levels. Many affected people have normal circulating testosterone. The problem is often the follicle’s heightened response to ordinary androgen exposure. Changes in hormone balance, such as those occurring with puberty, aging, or endocrine disorders, can reveal or accelerate the condition.
Environmental exposures may play a smaller but still relevant role. Chronic scalp inflammation, oxidative stress, ultraviolet exposure, and certain chemical irritants can affect the follicular environment. These factors do not usually cause androgenetic alopecia on their own, but they may worsen follicle vulnerability by increasing inflammatory signaling or impairing normal scalp biology.
Lifestyle factors may also influence how clearly the condition manifests. Severe nutritional deficiency, chronic psychological stress, poor sleep, and smoking can alter vascular function, inflammatory mediators, and cellular repair processes. These influences are not the primary drivers of androgenetic alopecia, but they can add physiologic stress to already vulnerable follicles and may make thinning more noticeable.
Infections are not a classic cause of androgenetic alopecia, but inflammatory scalp disorders or chronic infections can create a local environment that worsens follicle function. By increasing cytokine activity and tissue irritation, these conditions may reduce the follicle’s ability to maintain normal cycling.
How Multiple Factors May Interact
Androgenetic alopecia usually develops through the interaction of several biological systems rather than one isolated defect. Genetic susceptibility establishes the underlying framework: a follicle that is unusually responsive to androgens. Hormonal signaling then activates that susceptibility through DHT binding and downstream gene regulation. Local inflammation, oxidative stress, and microenvironmental changes can amplify the process by making follicles less stable and less capable of recovery between growth cycles.
The interaction is important because the same hormone exposure can lead to different outcomes in different people. One individual may have a genetically protected follicle that tolerates normal androgen levels without visible change. Another may inherit a follicle pattern that responds strongly to the same levels, leading to gradual miniaturization. Additional factors such as age-related decline, scalp inflammation, or endocrine changes can increase the speed or extent of thinning.
This is why androgenetic alopecia is best understood as a systems-level condition. Androgen signaling affects hair follicles, but the outcome depends on receptor sensitivity, enzyme activity, growth factor balance, tissue repair capacity, and the scalp environment working together.
Variations in Causes Between Individuals
The causes of androgenetic alopecia vary between individuals because the condition reflects a spectrum of biological susceptibility rather than a single pathway. In some people, the dominant factor is strong hereditary sensitivity to DHT. In others, the condition may not become apparent until hormonal shifts, aging, or another scalp condition increases follicle stress. The same diagnosis can therefore arise from different combinations of influences.
Age is a major reason for variation. In younger individuals, the main driver may be inherited follicular sensitivity that is already active but not yet fully expressed. In older adults, age-related changes in follicle cycling, reduced regenerative signaling, and cumulative hormonal exposure may make the pattern more visible. Health status also matters, because endocrine disease, metabolic disturbance, or chronic inflammation can alter the follicular response to androgen signaling.
Environmental exposure contributes to individual variation as well. Someone living with chronic scalp irritation, higher oxidative stress, or smoking-related vascular effects may experience more pronounced thinning than someone with the same genetic background but fewer environmental stresses. For this reason, two people with similar family histories can develop noticeably different severity and timing of hair loss.
Conditions or Disorders That Can Lead to Androgenetic alopecia
Certain medical conditions can contribute to or accelerate androgenetic alopecia by altering hormone balance or follicular sensitivity. Polycystic ovary syndrome is one example. It is associated with increased androgen activity in many affected women, and that hormonal environment can promote androgen-driven follicular miniaturization when the scalp is susceptible. The relationship is not simply one of elevated hormones; it also involves how the follicle interprets those hormones at the cellular level.
Disorders of the endocrine system can also play a role. Conditions affecting the adrenal glands or testes may change androgen production, while thyroid disorders can modify hair cycling and make underlying patterned hair loss more noticeable. Although thyroid disease does not cause classic androgenetic alopecia by the same pathway as DHT, it can alter the growth cycle and complicate the follicular response.
Metabolic conditions may contribute indirectly. Insulin resistance is associated with changes in ovarian and adrenal steroid metabolism in some individuals, which can affect androgen levels and tissue sensitivity. Chronic systemic inflammation and obesity may also influence hormone signaling and local scalp biology, increasing the likelihood that predisposed follicles become miniaturized.
Some inflammatory scalp disorders can interact with androgenetic alopecia by disturbing the follicle environment. Seborrheic dermatitis, for example, does not create the genetic susceptibility for the condition, but persistent inflammation and irritation may make existing pattern hair loss more apparent. Any disorder that repeatedly disrupts normal follicle cycling can add stress to follicles already vulnerable to androgen effects.
Conclusion
Androgenetic alopecia develops through the combined effects of inherited follicular sensitivity, androgen signaling, and progressive changes in the hair growth cycle. The central biological event is DHT acting on genetically susceptible follicles, leading to shortened growth phases and follicular miniaturization. Additional influences such as age, hormonal changes, scalp inflammation, environmental stressors, and certain medical conditions can affect when the condition begins and how quickly it progresses.
Understanding these mechanisms explains why androgenetic alopecia is not simply a matter of hair falling out. It is a regulated biological process in which follicles gradually shift toward producing finer hairs under the influence of genetics and hormones. The specific combination of causes differs from person to person, but the fundamental process is the same: a susceptible follicle responds abnormally to androgen-driven signals and slowly loses its capacity to maintain normal hair growth.